Results 21 to 30 of about 254,400 (263)

The effectiveness of cost-effectiveness analysis in containing costs [PDF]

open access: yesJournal of General Internal Medicine, 1998
Although cost-effectiveness analyses (CEAs) have been advocated as a tool to critically appraise the value of health expenditures, it has been widely hoped that they might also help contain health care costs. To determine how often they discourage additional expenditures, we reviewed the conclusions of recently published CEAs.A search of the Abridged ...
N A, Azimi, H G, Welch
openaire   +2 more sources

The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study

open access: yesBMC Neurology, 2012
Background The aim of this study was to estimate the one-year societal costs due to a stroke event in Italy and to investigate variables associated with costs in different phases following hospital admission.
Fattore Giovanni   +6 more
doaj   +1 more source

Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies [PDF]

open access: yes, 2002
As many more clinical trials collect economic information within their study design, so health economics analysts are increasingly working with patient-level data on both costs and effects.
Briggs, Andrew H   +9 more
core   +1 more source

Cost-benefit of hospitalization compared with outpatient care for pregnant women with pregestational and gestational diabetes or with mild hyperglycemia, in Brazil

open access: yesSão Paulo Medical Journal
CONTEXT AND OBJECTIVE: Pregnancies complicated by diabetes are associated with increased numbers of maternal and neonatal complications. Hospital costs increase according to the type of care provided.
Ana Claudia Molina Cavassini   +3 more
doaj   +1 more source

Quality of cost evaluations of physician continuous professional development: Systematic review of reporting and methods

open access: yesPerspectives on Medical Education, 2022
Introduction We sought to evaluate the reporting and methodological quality of cost evaluations of physician continuing professional development (CPD).
David A. Cook   +2 more
doaj   +1 more source

The cost of stroke in private hospitals in Brazil: a one-year prospective study

open access: yesArquivos de Neuro-Psiquiatria
Few studies from low- and middle-income countries have assessed stroke and cerebral reperfusion costs from the private sector. Objective To measure the in-hospital costs of ischemic stroke (IS), with and without cerebral reperfusion, primary ...
Luana Gabriela Dalla Rosa VIEIRA   +9 more
doaj   +1 more source

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe [PDF]

open access: yes, 2012
BACKGROUND: Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.
Amurwon, Jovita   +113 more
core   +1 more source

What does it cost? An economic analysis of a harm reduction intervention in Svetlogorsk, Belarus [PDF]

open access: yes, 2001
Given the expanding HIV epidemic among injecting drug users (IDUs) in Eastern Europe, there is a greater focus on harm reduction activities among IDUs.
Walker, D   +4 more
core   +4 more sources

The Costs of Burn Victim Hospital Care around the World: A Systematic Review

open access: yesIranian Journal of Public Health, 2021
Background: Burn injuries are very common and fire-related burns account for over 300,000 deaths per year globally. The costs of the treatment of these patients change around the world.
Pamela Alejandra Escalante Saavedra   +3 more
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy